The pharmaceutical Merck reduces the effectiveness of its pill against covid-19

La farmacéutica Merck rebaja la efectividad de su pastilla contra la covid-19

Photo: Kena Betancur / Getty Images

The American Pharmaceutical Company Merck downgraded the effectiveness of its oral drug to treat covid-19 in adult patients, who previously claimed that It was 50% and now it indicates that it is only 30%.

In a report published by the US Food and Drug Administration (FDA), Merck reported that final analyzes point to a 30% effectiveness of the pill, significantly below what the own company had said in October.

The drug Lagevrio (molnupiravir) is still being studied by the FDA for potential approval, which has confirmed for the moment that the use of the antiviral reduces the risk of being hospitalized and dying.

In October, Merck and Ridgeback Biotherapeutics, which developed the drug, applied for an authorization for emergency use from the US health authorities and requested marketing permits from other regulatory agencies around the world.

The medicine, Available in capsules, it should be taken twice daily day for 5 days, by adults with covid-19 who do not require supplemental oxygen and who are patients at risk of developing the disease in its serious condition.

For its part, the European Medicines Agency (EMA) began to evaluate the application for a marketing license in the European Union (EU) for molnupiravir.

See also  Outbreak of a rare infection: what is monkeypox?

The European regulator said it will “assess the benefits and risks” of Lagevrio “in a short period of time” and could issue an opinion on the license in “a few weeks” if the data presented by the pharmaceutical companies is sufficiently robust and complete to demonstrate efficacy. , the safety and quality of the drug.

The conclusion of the EMA will be reached in a shorter time because the Committee for Medicinal Products for Human Use (CHMP) has already advanced work in recent weeks, during the continuous evaluation of the drug, evaluating the data of the medicine as it became available. and shared by developers.

Keep reading:
– The United States will announce the purchase of 10 million Pfizer treatments against covid-19
– First homemade pill against covid-19; The US already analyzes it
– WHO names the new variant of the coronavirus an omicron


Leave a Comment

Your email address will not be published.